Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis
暂无分享,去创建一个
[1] J. Pawlotsky,et al. Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C. , 2004, The Journal of rheumatology.
[2] M. Michel,et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease. , 2003, The Journal of rheumatology.
[3] L. Punzi,et al. Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate , 2003, Annals of the rheumatic diseases.
[4] Y. Liaw. Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti‐hepatitis B virus therapy 1 , 2003, Journal of gastroenterology and hepatology.
[5] M. Neurath,et al. Treatment of Patients With Crohn's Disease and Concomitant Chronic Hepatitis C With a Chimeric Monoclonal Antibody to TNF , 2003, American Journal of Gastroenterology.
[6] G. Rossi. Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy , 2003, Leukemia & lymphoma.
[7] H. Conjeevaram,et al. Management of chronic hepatitis B. , 2003, Journal of hepatology.
[8] M. Manns,et al. Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation. , 2003, Journal of hepatology.
[9] D. Fong,et al. Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation , 2002, Hepatology.
[10] L. Biancone,et al. Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection. , 2002, Gastroenterology.
[11] Chi-hung Cheng,et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] R. D'Incà,et al. Hepatitis B and C Virus Infection in Crohn's Disease , 2001, Inflammatory bowel diseases.
[13] S. Chu,et al. Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4‐year experience , 2001, Journal of gastroenterology and hepatology.
[14] R. Perrillo. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. , 2001, Gastroenterology.
[15] A. Forbes,et al. Use of anti-tumour necrosis factor agents in inflammatory bowel disease , 2001, International Journal of Colorectal Disease.
[16] S. Campbell,et al. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection. , 2001, European journal of gastroenterology & hepatology.
[17] 丸澤 宏之. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen , 2000 .